Don’t tell everything in public: Deve Gowda advises grandson

Madikeri, Jun 5: Karnataka Minister for Revenue R Ashok said a Rs 10 crore grant would be released shortly for construction of a permanent building for 'Relief Centre' in Kodagu district which is vulnerable to floods because of its hilly landscape.

According to an official release here on Friday, the Minister symbolically handed over the newly built houses to flood victims in Jambur in Somwarpet on Thursday evening.

He said that whenever the 'Relief Centre' is vacant it will be used for government meetings.

Udupi, Mar 8: The 75-year old man who was admitted to Udupi District Hospital over suspected Corona Virus infection has tested negative on Saturday.

The reports from Bengaluru Medical College’s laboratory where the samples of the person were sent, confirmed that the aged person was not infected with Corona Virus.

The report was submitted to the District Administration by the laboratory that confirmed that the person was not infected by the viral Corona Virus.

The United States of America has bought almost the entire world's supply of remdesivir, one of just two drugs proven to treat COVID-19. 

“President Trump has struck an amazing deal to ensure Americans have access to the first authorised therapeutic for Covid-19,” said the US health and human services secretary, Alex Azar. 

“To the extent possible, we want to ensure that any American patient who needs remdesivir can get it. The Trump administration is doing everything in our power to learn more about life-saving therapeutics for Covid-19 and secure access to these options for the American people.”

The announcement implies that no other country in the world will be able to buy remdesivir for next three months at least.

The anti-viral drug patented by the US-based Gilead biotech firm is the only one approved by the European Medicines Agency (EMA) to treat patients with the novel coronavirus.

The Trump administration has already shown that it is prepared to outbid and outmanoeuvre all other countries to secure the medical supplies it needs for the US.

“They’ve got access to most of the drug supply [of remdesivir], so there’s nothing for Europe,” said Dr Andrew Hill, senior visiting research fellow at Liverpool University.

Remdesivir, the first drug approved by licensing authorities in the US to treat Covid-19, is made by Gilead and has been shown to help people recover faster from the disease. 

The first 140,000 doses, supplied to drug trials around the world, have been used up. The Trump administration has now bought more than 500,000 doses, which is all of Gilead’s production for July and 90% of August and September.